KAZUISTIKY Komplikácie po podaní mRNA vakcíny proti COVID-19 – kazuistika a krátky prehľad | E27 / Vnitř Lék. 2023;69(4):E20-E27 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz 22. Cushion S, Arboleda V, Hasanain Y, et al. Comorbidities and symptomatology of SARS ‑CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2)-related myocarditis and SARS ‑CoV-2 vaccine‑related myocarditis: A review. Cureus. 2022;14(4):e24084. 23. Fazlollahi A, Zahmatyar M, Noori M, et al. Cardiac complications following mRNA COVID-19 vaccines: A systematic review of case reports and case series. Rev Med Virol. 2022 Jul;32(4):e2318. 24. Patone M, Mei XW, Handunnetthi L, Dixon S, Zaccardi F, Shankar‑Hari M, et al. Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS‑CoV-2 infection. Nat Med. 2022;28(2):410-422. 25. Patone M, Mei XW, Handunnetthi L, et al. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS‑CoV-2 infection by age and sex. Circulation. 2022;146(10):743-754. 26. Heidecker B, Dagan N, Balicer R, et al. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. Eur J Heart Fail 2022; 24(11): 2000-2018. 27. Sanchez Tijmes F, Thavendiranathan P. Cardiac MRI assessment of nonischemic myocardial inflammation: state of the art review and update on myocarditis associated with COVID-19 vaccination. Radiol Cardiothorac Imaging. 2021;3(6):e210252. 28. Schauer J, Buddhe S, Gulhane A, et al. Persistent cardiac magnetic resonance imaging findings in a cohort of adolescents with post‑coronavirus disease 2019 mRNA vaccine myopericarditis. J Pediatr. 2022;245:233-237. 29. Ståhlberg M, Reistam U, Fedorowski A, et al. Post‑COVID-19 tachycardia syndrome: a distinct phenotype of post‑acute COVID-19 syndrome. Am J Med. 2021;134(12):1451-1456. 30. Becker RC. Autonomic dysfunction in SARS‑COV-2 infection acute and long‑term implications. COVID-19 editor’s page series. J Thromb Thrombolysis. 2021;52(3):692-707. 31. Mishra R, Banerjea AC. SARS‑CoV-2 spike targets USP33-IRF9 axis via exosomal miR- -148a to activate human microglia. Front Immunol. 2021;12:656700. 32. Shoenfeld Y, Ryabkova VA, Scheibenbogen C, et al. Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin Immunol. 2020;214:108384. 33. Takeda T, Morita H, Saito H, et al. Recent advances in understanding the roles of blood platelets in the pathogenesis of allergic inflammation and bronchial asthma. Allergol Int. 2018;67(3):326-333. 34. Theoharides TC, Cholevas C, Polyzoidis K, et al. Long‑COVID syndrome‑associated brain fog and chemofog: luteolin to the rescue. Biofactors. 2021;47(2):232-241. 35. Larsen NW, Stiles LE, Miglis MG. Preparing for the long‑haul: autonomic complications of COVID-19. Auton Neurosci. 2021;235:102841. 36. Brugada J, Katritsis DG, Arbelo E on behalf of the Task force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). 2019 ESC guidelines for the management of patients with supraventricular tachycardia. Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J. 2020;41(5):655-720. 37. Giannetti A, Filice E, Caffarelli C, et al. Mast Cell Activation Disorders. Medicina. 2021;57(2):124. 38. Kwan AC, Ebinger JE, Wei J, et al. Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS‑CoV-2 infection. Nat Cardiovasc Res. 2022;1:1187-1194. 39. Hermel M, Sweeney M, Abud E, et al. COVID-19 vaccination might induce postural orthostatic tachycardia syndrome: a case report. Vaccines (Basel). 2022;10(7):991. 40. Park J, Kim S, Lee J, An JY. A case of transient POTS following COVID-19 vaccine. Acta Neurol Belg. 2022;122(4):1081-1083. 41. Karimi Galougahi K. Autonomic dysfunction post‑inoculation with ChAdOx1 nCoV-19 vaccine. Eur Heart J Case Rep. 2021;5(12):ytab472. 42. Carroll HA, Millar E, Deans KA. Vitamin B12 and D deficiency as cofactors of COVID-19 vaccine‑induced chronic neurological adverse reactions: Two cases and a hypothesis. 8. 3. 2022, preprint (version1) available at Research Square: Available from: https://doi. org/10.21203/rs.3.rs-1425014/v1 43. Sanada Y, Azuma J, Hirano Y, et al. Overlapping myocarditis and postural orthostatic tachycardia syndrome after COVID-19 messenger RNA vaccination: a case report. Cureus. 2022;14(11):e31006. 44. Demopoulos C, Antonopoulou S, Theoharides TC. COVID-19, microthromboses, inflammation, and platelet activating factor. Biofactors. 2020 Nov;46(6):927-933. 45. Schenkel LC, Singh RK, Michel V, et al. Mechanism of choline deficiency and membrane alteration in postural orthostatic tachycardia syndrome primary skin fibroblasts. FASEB J. 2015;29(5):1663-1675. 46. Belcaro G, Cornelli U, Cesarone MR, et al. Preventive effects of Pycnogenol® on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19). Minerva Med. 2022;113(2):300-308. 47. Hansen KS, Mogensen TH, Agergaard J, et al. High‑dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: A randomized, phase 2, crossover trial. Lancet Reg Health Eur. 2022 Nov 2:100539. 48. Dalan R, Boehm BO. Micronutrient supplementation before COVID-19 vaccination can protect against adverse effects. Clin Nutr ESPEN. 2022;47:433-434. 49. Safavi F, Gustafson L, Walitt B, et al. Neuropathic symptoms with SARS‑CoV-2 vaccination. medRxiv [Preprint] 2022 May 17:2022. 05. 16.22274439. 50. Finsterer J. Small fiber neuropathy as a complication of SARSCoV2 vaccinations. J Family Med Prim Care. 2022;11:4071-4073.
RkJQdWJsaXNoZXIy NDA4Mjc=